Thomas Arnold is the Chief Executive Officer of Kaleido. They previously served as Vice President Global Marketing at PROCEPT BioRobotics (2023–2024), where they transformed the marketing organization and led initiatives that grew sales from $75M in 2022 to about $225M in 2024. They led the development and market launch of HYDROS, Procept's AI-powered surgical robot, and expanded digital engagement by launching two new websites that increased web traffic by 50%. From 2021 to 2023, they held senior leadership roles at Medtronic, including Vice President Commercial Strategy and Enablement, Senior Director - Health Plan Solutions, and Senior Director - Value-Based Strategy and Partnerships. Their career also includes positions at Sorin Group (Senior Director - Strategic Growth Initiatives; Global Business Leader - Tachycardia and Heart Failure), Boston Scientific (2007–2010), Deloitte (Senior Consultant, 2001–2003), and Quadion Corp (Industrial Engineer; Shift Operations Manager; Program Manager with P&L, 1995–1996); they attended the University of Michigan Ross School of Business from 1999 to 2001.
This person is not in the org chart
This person is not in any teams
This person is not in any offices